These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1964796)

  • 41. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.
    Kurebayashi J; McLeskey SW; Johnson MD; Lippman ME; Dickson RB; Kern FG
    Cancer Res; 1993 May; 53(9):2178-87. PubMed ID: 8481921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
    Callahan R; Smith GH
    Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus.
    Peters G; Lee AE; Dickson C
    Nature; 1986 Apr 17-23; 320(6063):628-31. PubMed ID: 3010125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
    Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C
    Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
    Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
    Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
    Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320).
    Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G
    Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.
    Kiyozuka Y; Asai A; Senzaki H; Uemura Y; Nakashima A; Morimoto J; Matsuzawa A; Tsubura A
    Int J Mol Med; 1998 Oct; 2(4):437-44. PubMed ID: 9857231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression, cellular diversification and tumor progression to the metastatic phenotype.
    Nicolson GL
    Bioessays; 1991 Jul; 13(7):337-42. PubMed ID: 1759975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
    Vaage J; Medina D
    Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lectin-binding patterns in transplantable mouse mammary tumors and their metastases.
    Tsubura A; Morii S; Matsuzawa A
    Anticancer Res; 1991; 11(5):1719-23. PubMed ID: 1768042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene.
    Furuya Y; Sato N; Watabe Y; Shimazaki J
    Jpn J Cancer Res; 1991 Nov; 82(11):1245-51. PubMed ID: 1836456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous progression of hyperplastic outgrowths of the D1 lineage to mammary tumors: expression of mouse mammary tumor virus and cellular proto-oncogenes.
    Knepper JE; Kittrell FS; Medina D; Butel JS
    Mol Carcinog; 1989; 1(4):229-38. PubMed ID: 2551332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progression toward metastatic phenotype with loss of growth-inhibiting tumor-cell/cell interactions in vivo.
    Takeda Y; Sayama K; Saegusa Y; Matsuzawa A
    Int J Cancer; 1995 Sep; 62(5):579-84. PubMed ID: 7665229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors.
    Tsubura A; Inui T; Morii S; Dairkee SH; Oikawa T; Matsuzawa A
    Breast Cancer Res Treat; 1991; 17(3):239-43. PubMed ID: 1710155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.